STOCK TITAN

OrthoPediatrics Corp. - KIDS STOCK NEWS

Welcome to our dedicated page for OrthoPediatrics news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics stock.

OrthoPediatrics Corp. (symbol: KIDS) is a global leader in pediatric orthopedics, exclusively focusing on providing innovative solutions for children with orthopedic conditions and injuries. The company is dedicated to advancing pediatric orthopedics by developing state-of-the-art technologies, ensuring high-quality products, and offering unparalleled support and clinical education through its team of experts.

OrthoPediatrics offers a wide range of anatomically appropriate implants and instruments designed to meet the unique needs of pediatric orthopedic surgeons. Their product portfolio includes solutions for long bone deformity correction and trauma, spine, and sports medicine. Among their flagship products are PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

Recent achievements of OrthoPediatrics include issuing the 2024 financial guidance and recording a full-year revenue of $148.7 million in 2023, marking a 22% increase compared to the previous year. As of December 31, 2023, the company had cash and cash equivalents, short-term investments, and restricted cash totaling $82.3 million. The recent acquisition of Boston Orthotics & Prosthetics was a significant milestone, further reinforcing their market position.

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year. The company's total other expense was $0.6 million for the quarter, primarily due to a favorable fair value adjustment in the previous year that did not recur in 2024, as well as additional interest expenses related to a new term loan with MidCap. As of March 31, 2024, the company's cash, cash equivalents, short-term investments, and restricted cash were $49.7 million.

OrthoPediatrics continues to seek talented professionals to join their mission. Interested candidates can visit their website to learn about current openings or submit their resumes to careers@orthopediatrics.com. For the latest updates, news, and developments, shareholders and potential investors can find the most recent information on OrthoPediatrics Corp. through this page.

Rhea-AI Summary
OrthoPediatrics Corp. sponsored the 58th Annual Meeting for the Scoliosis Research Society, showcasing the ApiFix technology for treating Adolescent Idiopathic Scoliosis. The company highlighted its commitment to pediatric orthopedic patients and non-fusion technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. to participate in Gilmartin Group Emerging Growth Company Showcase on September 21, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.57%
Tags
conferences acquisition
-
Rhea-AI Summary
OrthoPediatrics Corp. has received FDA clearance for its Pediatric Nailing Platform | Tibia surgical system, expanding its offering to 51 unique surgical systems designed for pediatric patients. The system is expected to launch in Q3 2023 and features specialized instrumentation to facilitate multiple surgical techniques. This expansion is seen as a positive move for the company's growth prospects.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.6%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.83%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.08%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. announced the election of George Dyer, MD to its Board of Directors. Dr. Dyer is an upper extremity surgeon and an Associate Professor of Orthopedic Surgery at Harvard Medical School. His expertise will contribute to the company's product portfolio strategy and development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.25%
Tags
Rhea-AI Summary
OrthoPediatrics Corp. announces its continued support of the 2023 Pediatric Orthopaedic Society of North America annual meeting. The company highlighted its pediatric-specific solutions and sponsored a sub-specialty session on hip dysplasia. OrthoPediatrics also showcased progress with the ApiFix non-fusion technology and established a longer-term commitment to POSNA as the only Emerald Sponsor.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.05%
Tags
none

FAQ

What is the current stock price of OrthoPediatrics (KIDS)?

The current stock price of OrthoPediatrics (KIDS) is $26.34 as of November 22, 2024.

What is the market cap of OrthoPediatrics (KIDS)?

The market cap of OrthoPediatrics (KIDS) is approximately 637.8M.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. designs, develops, and commercializes implants and instruments specifically for pediatric orthopedic surgeons to treat children with orthopedic conditions and injuries.

What are some of OrthoPediatrics' key products?

Key products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

What were OrthoPediatrics' financial highlights for 2023?

OrthoPediatrics recorded a full-year revenue of $148.7 million in 2023, a 22% increase compared to the prior year.

How did OrthoPediatrics perform in the first quarter of 2024?

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year, with total other expense at $0.6 million.

What recent acquisition did OrthoPediatrics make?

OrthoPediatrics recently acquired Boston Orthotics & Prosthetics, further reinforcing their market position.

How much cash and equivalents did OrthoPediatrics have as of March 31, 2024?

As of March 31, 2024, OrthoPediatrics had $49.7 million in cash, cash equivalents, short-term investments, and restricted cash.

What is OrthoPediatrics' focus in pediatric orthopedics?

OrthoPediatrics focuses on advancing pediatric orthopedics by developing state-of-the-art technologies, high-quality products, and offering industry-leading support and clinical education.

Where can I learn about career opportunities at OrthoPediatrics?

You can learn about current openings and career opportunities at OrthoPediatrics by visiting their website or submitting a resume to careers@orthopediatrics.com.

Who can I contact for investor relations at OrthoPediatrics?

For investor relations, you can contact Philip Taylor at Gilmartin Group via email at philip@gilmartinir.com or phone at 415-937-5406.

What recent financial guidance did OrthoPediatrics issue?

OrthoPediatrics recently issued their 2024 financial guidance, which includes detailed projections and expectations for the year.

OrthoPediatrics Corp.

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

637.85M
16.34M
32.52%
70.85%
3.77%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WARSAW